In an AD model based on overexpression of a mutant version of human Tau, results from a genetic screening showed that increasing or reducing the expression of a dZip42C.1 and dZnT63C successfully modified Tau-related phenotypes in the fly (Huang et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.